Jefferies Financial Group Inc. Glycomimetics Inc Transaction History
Jefferies Financial Group Inc.
- $10.7 Billion
- Q1 2025
A detailed history of Jefferies Financial Group Inc. transactions in Glycomimetics Inc stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 585,000 shares of GLYC stock, worth $122,850. This represents 0.0% of its overall portfolio holdings.
Number of Shares
585,000
Previous 423,777
38.04%
Holding current value
$122,850
Previous $105,000
16.19%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding GLYC
# of Institutions
38Shares Held
30.8MCall Options Held
80.9KPut Options Held
20.8K-
Bvf Inc San Francisco, CA9.54MShares$2 Million0.09% of portfolio
-
Logos Global Management LP San Francisco, CA5.4MShares$1.13 Million0.22% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.09MShares$1.07 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY3MShares$630,0000.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$560,7430.0% of portfolio
About GLYCOMIMETICS INC
- Ticker GLYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,423,900
- Market Cap $11M
- Description
- GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...